These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 8571743

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Immunophenotyping in acute leukemia: detection of minimal residual disease].
    Pálóczi K, Nahajevszky S, Jakab K, Regéczy N, Gopcsa L, László E, Földi J.
    Orv Hetil; 2000 Nov 12; 141(46):2487-92. PubMed ID: 11126681
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Increased myeloid precursors in regenerating bone marrow; implications for detection of minimal residual disease in acute myeloid leukemia.
    Zeleznikova T, Stevulova L, Kovarikova A, Babusikova O.
    Neoplasma; 2007 Nov 12; 54(6):471-7. PubMed ID: 17949229
    [Abstract] [Full Text] [Related]

  • 10. [The minimal residual disease (MRD) in hematological malignancies].
    Yokota S, Okamoto T.
    Gan To Kagaku Ryoho; 2001 Jun 12; 28(6):762-8. PubMed ID: 11432342
    [Abstract] [Full Text] [Related]

  • 11. PRAME mRNA levels in cases with acute leukemia: clinical importance and future prospects.
    Paydas S, Tanriverdi K, Yavuz S, Disel U, Baslamisli F, Burgut R.
    Am J Hematol; 2005 Aug 12; 79(4):257-61. PubMed ID: 16044453
    [Abstract] [Full Text] [Related]

  • 12. [Detection of minimal residual disease in patients with acute myeloid leukemia].
    Gal'tseva IV, Savchenko VG, Kulikov SM, Parovichnikova EN, Miterev GIu, Maslova ER, Isaev VG.
    Ter Arkh; 2003 Aug 12; 75(7):8-14. PubMed ID: 12934474
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Wilms tumour gene 1 overexpression in bone marrow as a marker for minimal residual disease in acute myeloid leukaemia.
    Hämäläinen MM, Kairisto V, Juvonen V, Johansson J, Aurén J, Kohonen K, Remes K, Salmi TT, Helenius H, Pelliniemi TT.
    Eur J Haematol; 2008 Mar 12; 80(3):201-7. PubMed ID: 18081724
    [Abstract] [Full Text] [Related]

  • 15. A method comparison study of flow cytometry and cytomorphology to determine the percentages of blasts in patients with acute leukemia after induction and consolidation chemotherapy.
    Wongprajun S, Auewarakul CU.
    J Med Assoc Thai; 2010 Jan 12; 93 Suppl 1():S157-64. PubMed ID: 20364570
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Leukemia-associated phenotypes: their characteristics and incidence in acute leukemia.
    Babusíková O, Glasová M, Koníková E, Kusenda J.
    Neoplasma; 1996 Jan 12; 43(6):367-72. PubMed ID: 8996560
    [Abstract] [Full Text] [Related]

  • 19. Overexpression of CD49f in precursor B-cell acute lymphoblastic leukemia: potential usefulness in minimal residual disease detection.
    DiGiuseppe JA, Fuller SG, Borowitz MJ.
    Cytometry B Clin Cytom; 2009 Mar 12; 76(2):150-5. PubMed ID: 18831072
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.